A Randomized, Double-Blind, Parallel-Group, Placebo and Active Comparator (Pioglitazone)-Controlled Clinical Study to Determine the Efficacy and Safety of Balaglitazone in Patients With Type 2 Diabetes on Stable Insulin Therapy.
Latest Information Update: 10 Nov 2021
At a glance
- Drugs Balaglitazone (Primary) ; Pioglitazone
- Indications Type 2 diabetes mellitus
- Focus Registrational; Therapeutic Use
- Acronyms BALLET
- Sponsors Rheoscience
- 08 Sep 2016 Results (per protocol set n=297) of secondary post-hoc analysis of this study assessing correlation between endotrophin levels and measures of glucose control, published in the Diabetologia Journal.
- 28 Jun 2011 Results presented at the 71st Annual Scientific Sessions of the American Diabetes Association.
- 22 Jul 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.